Karolina Rask

Karolina has a background as a molecular biologist and started her career in clinical research as a clinical research assistant (CRA). She has held a variety of positions in Sweden, Denmark, UK and USA within both biotech, CRO and pharma. For a few years she was the CEO of a small virtual biotech working in critical care, but most recently within clinical development at AstraZeneca. She currently holds a position at Pfizer as Director Clinical Site Management for the UK, Ireland and the Nordics.